Concepedia

Erol Wiegert

EW

Statistics

Publications

8

Citations

577

H-Index

8

Active since

2011

Affiliations

Bexon Clinical Consulting (United States)(Current)

University Medical Center Hamburg-Eppendorf

University Hospital Cologne

Charité - Universitätsmedizin Berlin

University Medical Center of the Johannes Gutenberg University Mainz

Erol Wiegert is an author at Bexon Clinical Consulting (United States) specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

2011–2023

8

Publications

8

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Andréas Mackensen, John B.A.G. Haanen, Christian Koenecke et al. · Nature Medicine · 2023 · 261 citations · Full text

, , +17

Effective elimination of dabigatran by haemodialysis

Stephan Formella, Erol Wiegert, Viktoria Moschetti et al. · Thrombosis and Haemostasis · 2013 · 206 citations

, , +17

Ile-Pro-Pro and Val-Pro-Pro Tripeptide-Containing Milk Product has Acute Blood Pressure Lowering Effects in Mildly Hypertensive Subjects

Anu M. Turpeinen, Pauliina I. Ehlers, Anne S. Kivimäki et al. · Clinical and Experimental Hypertension · 2011 · 33 citations

, , +17

Phase 1 trial of the adenosine A<sub>2A</sub> receptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A<sub>2A</sub> receptor within the tumor.

Laurence Buisseret, Sylvie Rottey, Johann S. de Bono et al. · Journal of Clinical Oncology · 2021 · 18 citations · Full text

, , +4

958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

Andréas Mackensen, Christian Koenecke, John Haanen et al. · 2021 · 17 citations · Full text

, , +17

1–5 of 8